Trial Profile
Investigating the Mechanism of Inhaled Corticosteroids Associated Pneumonia by Longitudinal Characterisation of the Airway Microbiome in Patients With Severe COPD
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Aclidinium bromide (Primary) ; Budesonide/formoterol (Primary) ; Formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms MUSIC
- 05 Dec 2019 Status changed from active, no longer recruiting to discontinued.
- 04 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 07 Sep 2018 Planned End Date changed from 1 May 2018 to 1 Apr 2020.